News

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...
The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...
Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not uncommon for individuals to seek out a weight management aid, such as a ...
As more CFOs step into the public spotlight by participating in events and conferences, the cost of misspeaking and the importance of leadership alignment on policy are increasing.
Zepbound is the latest GLP-1 receptor agonist medication to be approved for weight loss. ... Ro offers an online weight loss program that combines on-demand coaching with weight loss medications, ...
Evernorth is offering the weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide) to patients at a monthly cost of no more than $200, which will also count toward patients’ deductibles.
Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an add-on to its pharmacy benefit management plans, the company announced ...
RO is a DTP telehealth company that provides nationwide services. The company offers multiple GLP-1 options and has hired a familiar face to promote them. 1. ... In the same press release, Reitano ...
The move will knock Lilly’s dual GIP/GLP-1 receptor agonist for obesity, Zepbound, ... LifeMD and Ro—to help patients access branded Wegovy through its NovoCare online pharmacy.
Barkley will star in a series of ads for Ro’s GLP-1 offering, starting with a 30-second spot that sets out his ambition to lose 65 pounds. The ad shows Barkley sitting on a film set, where ...
As part of its deal with Novo, Hims, along with LifeMD Inc., and Ro will sell a month’s supply of Wegovy starting at $499, a 63 percent discount, before subscription fees.